Growth Factor Concentrate (GFC) for the Management of Osteoarthritis of the Knee: A Systematic Review
In brief
A systematic review of growth factor concentrate (GFC), an injection prepared from the patient’s own blood, for knee osteoarthritis. Only a few clinical studies qualified; they suggest it is safe and may help. The authors call for larger randomised trials, including comparisons with other orthobiologic treatments, before routine use can be justified.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Growth Factor Concentrate (GFC) for the Management of Osteoarthritis of the Knee: A Systematic Review Authors: Ashim Gupta & Nicola Maffulli Link: https://link.springer.com/article/10.1007/s43465-024-01172-w Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

